Benzinga | Nov 30, 2021 04:44PM EST

JMP Securities Initiates Coverage On Cellectis with Market Outperform Rating, Announces Price Target of $20

JMP Securities analyst Silvan Tuerkcan initiates coverage on Cellectis (NASDAQ:CLLS) with a Market Outperform rating and announces Price Target of $20.